News Author: Jennifer Smith Publish date: May 11, 2019
NEW ORLEANS – The test detected pathogens with 92% sensitivity, which was more sensitive than conventional testing methods.
News Author: Jennifer Smith Publish date: May 10, 2019
The inhibitor, IACS-010759, decreased tumor growth and prolonged survival in mouse models of ibrutinib-resistant lymphoma.
Video Author: Jennifer Smith Publish date: May 8, 2019
NEWPORT BEACH, CALIF. – Investigators used machine learning algorithms to risk stratify patients with normal karyotype acute myeloid leukemia.
News Author: Jennifer Smith Publish date: May 6, 2019
NEW ORLEANS – Gabapentin plus standard therapy produced results similar to those of placebo plus standard therapy.
News Author: Jennifer Smith Publish date: May 6, 2019
Five teams received funding for research into leukemia and lung, colon, pancreatic, breast, and ovarian cancers.
Video Author: Jennifer Smith Publish date: May 3, 2019
NEWPORT BEACH, CALIF. – Oral rigosertib plus azacitidine produced a 90% response rate in higher-risk patients with myelodysplastic syndromes who ha...
Video Author: Jennifer Smith Publish date: May 3, 2019
NEWPORT BEACH, CALIF. – Patients with more than 60% cytogenetically abnormal cells at transplant had inferior overall survival and relapse-free sur...
News Author: Jennifer Smith Publish date: May 3, 2019
NEW ORLEANS – Children and young adults with non-beta0 /beta0 thalassemia achieved transfusion independence in two trials.
Video Author: Jennifer Smith Publish date: April 26, 2019
NEWPORT BEACH, CALIF. – Testing patient blood samples for two biomarkers may help guide early treatment of acute GVHD.
News Author: Jennifer Smith Publish date: April 24, 2019
The overall response rate was 90% in previously untreated patients who received the highest dose.
Video Author: Jennifer Smith Publish date: April 23, 2019
NEWPORT BEACH, CALIF. – The researchers used an algorithm to help predict response or resistance to lenalidomide with a high degree of accuracy.
News Author: Jennifer Smith Publish date: April 22, 2019
Hematology and oncology researchers will receive awards at the 2019 American Society of Pediatric Hematology/Oncology conference.
Video Author: Jennifer Smith Publish date: April 22, 2019
NEWPORT BEACH, CALIF. – Sorafenib plus GCLAM has shown promise in a phase 1 trial of patients with AML and MDS.
Video Author: Jennifer Smith Publish date: April 19, 2019
NEWPORT BEACH, CALIF. – Researchers identified transgender leukemia patients by detecting gender-karyotype mismatches.
Video Author: Jennifer Smith Publish date: April 19, 2019
NEWPORT BEACH, CALIF. – Dr. Martin Tallman discusses meeting presentations on the treatment of AML.
